M 228 (Pioglitazone hydrochloride 30 mg (base))

Pill imprint M 228 has been identified as Pioglitazone hydrochloride 30 mg (base).

Pioglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 30 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 228

Pioglitazone hydrochloride 30 mg (base) M 228
Pioglitazone hydrochloride
Imprint:
M 228
Strength:
30 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0228
Inactive Ingredients:
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
sodium starch glycolate type A potato

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)